Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,804,351 | $25,976,014 | $27,965,605 | $34,175,010 |
| - Cash | $1,924,594 | $11,827,223 | $14,510,832 | $18,273,150 |
| + Debt | $2,919,426 | $13,265,109 | $11,546,493 | $12,374,236 |
| Enterprise Value | $4,799,182 | $27,413,900 | $25,001,266 | $28,276,096 |
| Revenue | $2,774,965 | $19,361,138 | $22,473,408 | $15,932,820 |
| % Growth | -85.7% | -13.8% | 41.1% | – |
| Gross Profit | $446,599 | $3,053,473 | $4,609,766 | $2,063,793 |
| % Margin | 16.1% | 15.8% | 20.5% | 13% |
| EBITDA | $167,690 | $961,816 | $2,332,601 | -$297,781 |
| % Margin | 6% | 5% | 10.4% | -1.9% |
| Net Income | $111,427 | $694,828 | $1,821,313 | -$323,481 |
| % Margin | 4% | 3.6% | 8.1% | -2% |
| EPS Diluted | 0.069 | 0.43 | 1.12 | -0.2 |
| % Growth | -84.1% | -61.6% | 660% | – |
| Operating Cash Flow | $237,237 | $500,122 | -$3,897,258 | $0 |
| Capital Expenditures | -$58,703 | -$270,710 | -$226,496 | -$316,168 |
| Free Cash Flow | $178,534 | $229,412 | -$4,123,754 | $3,877,621 |